AK1
protein-codingadenylate kinase 1, the group of MicroRNA protein coding host genes|Adenylate kinases
Gene summary
This gene encodes an adenylate kinase enzyme involved in energy metabolism and homeostasis of cellular adenine nucleotide ratios in different intracellular compartments. This gene is highly expressed in skeletal muscle, brain and erythrocytes. Certain mutations in this gene resulting in a functionally inadequate enzyme are associated with a rare genetic disorder causing nonspherocytic hemolytic anemia. Alternative splicing of this gene results in multiple transcript variants encoding different isoforms. This gene shares readthrough transcripts with the upstream ST6GALNAC6 gene. [provided by RefSeq, Jan 2022]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~11.2 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0012967
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0012967
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0012967
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0012967
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Hematologic; Neurologic
Intervention: Hematologic
Rationale: Individuals present with hemolytic anemia (as well as neurodevelopmental features, at least in some reported individuals), and splenectomy has reported as being effective in treatment of hemolysis
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to AK1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000476.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 18 | 1 | 19 | |||
| missense | 5 | 1 | 44 | 3 | 53 | |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 1 | 3 | 4 | |||
| Total | 6 | 4 | 47 | 21 | 1 | 79 |
Highest pathogenic variant AF is 0.00001577049
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000467.1 | 6 | MANE Select | |
| Ensembl | ENSP00000494600.1 | 6 | MANE Select | |
| RefSeq | NP_001305050.1 | 6 | Standard | |
| RefSeq | NP_001305051.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Purine metabolism - Homo sapiens (human)
- Thiamine metabolism - Homo sapiens (human)
- Purine Nucleoside Phosphorylase Deficiency
- Mercaptopurine Action Pathway
- Azathioprine Action Pathway
Biological Process
- nucleoside diphosphate phosphorylation
- ADP biosynthetic process
- nucleoside triphosphate biosynthetic process
- nucleobase-containing small molecule interconversion
- AMP metabolic process
Molecular Function
- adenylate kinase activity
- nucleoside diphosphate kinase activity
- ATP binding
Cellular Component
- cytosol
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000373176
- Coding exons
- 6
- Length
- 11264
- Individuals with no LoFs
- 125556
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 184
- Defined
- 125740
- p
- 0.000732
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.649 | 96 | 116 | 0.830 | 0.00000767 | 1224 |
| Missense (PolyPhen) | 42 | 58.242 | 0.72112 | 538 | ||
| Synonymous | 0.189 | 47 | 48.7 | 0.966 | 0.00000333 | 386 |
| Loss of Function | 1.71 | 4 | 9.77 | 0.410 | 5.07e-7 | 127 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0029 | 0.0028 | notable |
| Latino/Admixed American | 0.00020 | 0.00020 | rare |
| Ashkenazi Jewish | 0.00070 | 0.00069 | rare |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.0012 | 0.0012 | notable |
| European (Non-Finnish) | 0.00072 | 0.00071 | rare |
| South Asian | 0.000067 | 0.000065 | rare |
| Other | 0.0018 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Catalyzes the reversible transfer of the terminal phosphate group between ATP and AMP. Also displays broad nucleoside diphosphate kinase activity. Plays an important role in cellular energy homeostasis and in adenine nucleotide metabolism. {ECO:0000255|HAMAP-Rule:MF_03171, ECO:0000269|PubMed:23416111}.;
- Disease
- DISEASE: Hemolytic anemia due to adenylate kinase deficiency (HAAKD) [MIM:612631]: A disease characterized by hemolytic anemia and undetectable erythrocyte adenylate kinase activity. {ECO:0000269|PubMed:12649162, ECO:0000269|PubMed:2542324, ECO:0000269|PubMed:9432020}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.643
Intolerance Scores
- LoFtool
- 0.377
- RVIS EVS
- -0.14
- RVIS percentile EVS
- 43.57
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.960
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |